CDK7 inhibition promotes glioblastoma cell death through convergent transcriptional and metabolic stress pathways
Saved in:
| Main Authors: | Thomas Freitag, Jana Vanessa Scheffler, Philipp Kaps, Anne Hieltscher, Björn Schneider, Daniel Dubinski, Florian Gessler, Thomas M. Freiman, Felix Wittig, Sascha Troschke‐Meurer, Wendy Bergmann‐Ewert, Susanne Staehlke, Lars Boeckmann, Philipp‐Kjell Ficht, Christian Polley, Christian Junghanss, Burkhard Hinz, Claudia Maletzki |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | Clinical and Translational Medicine |
| Online Access: | https://doi.org/10.1002/ctm2.70448 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CDK inhibitors promote neuroblastoma cell differentiation and increase sensitivity to retinoic acid—a promising combination strategy for therapeutic intervention
by: Fatemeh Shokraie, et al.
Published: (2025-08-01) -
Thymidine kinase 1 concentration and activity in metastatic breast cancer under CDK4/6 inhibitor therapy
by: Stefanos Ioannis Moukas, et al.
Published: (2025-03-01) -
CDK7/12/13 inhibition targets an oscillating leukemia stem cell network and synergizes with venetoclax in acute myeloid leukemia
by: Lixiazi He, et al.
Published: (2022-03-01) -
CDK9 is a prognostic marker and therapeutic target in pancreatic cancer
by: Anna-Laura Kretz, et al.
Published: (2017-02-01) -
CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
by: Sara Costa-Cabral, et al.
Published: (2016-01-01)